Log in

Register Subscribe
The Home of Textile Innovation

ZURICH – Swiss textile innovator HeiQ is offering its new Viroblock NPJO3 antimicrobial treatment to industry peers, insisting that collaboration and the protection of those in the infection’s firing line is of utmost importance.

HeiQ Viroblock is a combination of vesicle and silver technologies and works by binding to viral sulfur groups and depleting their membranes to render them less infectious and harmful.  

When used to coat facemasks, the treatment has been found to improve the protective properties of these PPE items by 30 times, and thus would be an asset for more firms to use.

Why Subscribe?

T.EVO BACK ISSUE ARCHIVE
OTHER PUBLICATIONS FROM MCL GLOBAL

Weekly e-news bulletin

Latest news direct to your inbox

Interested in advertising?

Simply give us a call

Sales: +44 1977 708488

Or if you prefer email, click on the button below and we'll get back to you asap

 

Why Subscribe?

Looking beyond the cutting edge of textile innovation allows you to stay well ahead of the competition. That’s exactly what you get through a subscription to T.EVO – which delivers a refreshing new take on the rapid evolution of today’s dynamic textile sector.

Key T.EVO benefits:

You will learn about:

All this from MCL Global – the fastest growing international textile publisher – which can now offer today’s textile industry a unique preview of how today’s industry will look tomorrow.

In print, online and mobile device formats.